Home
Drugs
Targets
Pathways
Ontologies
Cyp450s
Adv.search
Help/FAQ

Drug Details

add
Name:Clazosentan
PubChem ID:6433095
Pathway:Show KEGG pathways
InChI:InChI=1S/C25H23N9O6S/c1-15-7-8-20(27-14-15)41(36,37)32-24-21(40-19-6-4-3-5-18(19)38-2)25(39-12-11-35)29-22(28-24)16-9-10-26-17(13-16)23-30-33-34-31-23/h3-10,13-14,35H,11-12H2,1-2H3,(H,28,29,32)(H,30,31,33,34)
SMILES:OCCOc1nc(nc(c1Oc1ccccc1OC)NS(=O)(=O)c1ccc(cn1)C)c1ccnc(c1)c1nn[nH]n1

Properties:
Formula:C25H23N9O6SAtoms:41
Molecular Weight:577.572Rotatable Bonds:11
H-bond Acceptors:14H-bond Donors:3
logP:3.5487
Targets:
Synonyms:
()-oxazepam hemisuccinate sodium salt
180384-56-9
AC1O5FK3
AXV 034
AXV 034343
AXV 343434
AXV-034
AXV-034343
AXV-343434
AXV343434
C109641
CHEBI:282389
CHEMBL109648
Clazosentan
Clazosentan [INN]
N-(6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1H-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin
N-{6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1H-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl}-5-methylpyridine-2-sulfonamide
Ro 61-1790
Ro-61-1790
UNII-3DRR0X4728
VML 588
VML-588
VML588